<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>revista-medicina-scolara</PublisherName>
      <JournalTitle>The Journal of School and University Medicine</JournalTitle>
      <PISSN/>
      <EISSN/>
      <Volume-Issue>Volume 5 Issue 1</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>January 2018</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>2018</Year>
        <Month>01</Month>
        <Day>28</Day>
      </PubDate>
      <ArticleType>Medical</ArticleType>
      <ArticleTitle>Arterial hypertension in adolescents - prospective study</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>5</FirstPage>
      <LastPage>15</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Adriana</FirstName>
          <LastName>Neghirla</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Iacobina</FirstName>
          <LastName>Rus</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Cornelia</FirstName>
          <LastName>Hategan</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Mihaela</FirstName>
          <LastName>Onose</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Liliana</FirstName>
          <LastName>Heinrich</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Dumitrita</FirstName>
          <LastName>Barsan</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Natalia-Stela</FirstName>
          <LastName>Dalalau-Rus</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Anica</FirstName>
          <LastName>Oroian</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Mariana</FirstName>
          <LastName>Samsudean</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>High blood pressure is present and adolescents being a predictor of HTA and cardiovascular disease in adults. &#13;
&#13;
PURPOSE: Assessing the current prevalence of HTA cases in adolescents and the presence of risk factors for early diagnosis and the introduction of primary, secondary or tertiary prophylaxis. &#13;
&#13;
MATERIAL AND METHOD: Group: 717 adolescents from 7 high schools in Mures county, aged 15-20 years, sex ratio M: F = 1: 0.96, average Urban: Rural = 0.89: 1. Period: 15.02.2017 - 30.03.2017. Method: measurement of G, H, BMI, BP, SaO2, personal pathological antecedents, AHC relatives grd 1__ampersandsign,2 (HTA,T1,2 DM), risk behaviors (tobacco, alcohol, energy drinks at least 1x / week. Statistica:, maximum, average, chi squared test. &#13;
&#13;
RESULTS: HTA prevalence 18.13% (n = 130), girls 14.77% (n = 52) boys 21.36% (n = 78), urban 6.83% (n = 49) , 29% (n = 81). Evaluation of TAS and TAD based on age, sex, height (percentiles): normal TAS (nTAS) 84.51% (n = 606) and TAD (nTAD) 79% (n = 588) 98% (n = 7), TAD 0.41% (n = 3),  HTA: TAS 14.5% (n = 104), TAD 6.837% (n = 49); preHTA: TAS 5.44%, TAD 14.39%, high risk of HTA. HTAS at 13.47% (n = 66) of normoponderal (n = 490), + G (n = 110) to 30.91% (n = 34) (n = 4) (p = 0.000003). HTAD (n = 49) adolescents, +G 34.69% (n = 17), -G 8.16% (n = 4), normoponeral 57.14% (n = 28). Risk behaviors (minimum 1 x / week): smokes 27.05% (n = 194), alcohol 8.5% (n = 61), energy drinks 21% (n = 149). HTA (n = 130): smokers 23.84% (n = 31), alcohol 6.15% (n = 8), energy drinks 17.69% (n = 23) (n = 14). Adolescents with HTA + grade 1 and 2 relatives with HTA 21.53% (n = 28), diabetes mellitus 10% (n = 13). (BMI &gt; + 1) + HTA + relatives with HTA +T2 DM 4.61% (n = 6), (BMI &lt; -1) + HTA + relatives with T2DM 4.61% (n = 6).&#13;
&#13;
CONCLUSIONS: 1. HTA in adolescents is much underdiagnosed and is one of the risk factors associated with the risk for cardiovascular events. 2. The presence of many HTA associated risk factors (obesity, risk behaviors, family factors, etc.) is a public health problem . 3. The need for complex screening and programs to prevent cardiovascular disease from childhood, school medicine being an important resource in their implementation.4. Health education and nutrition education conducted professionally, continuously and according to a coherent program are pressing needs, given that lifestyle is particularly important in both HTA prevention and treatment.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords/>
      <URLs>
        <Abstract>https://revista-medicina-scolara.ro/ubijournal-v1copy/journals/abstract.php?article_id=9296&amp;title=Arterial hypertension in adolescents - prospective study</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. In: Pediatrics  2004; 114(2):555-576&#13;
	Palii I, Rudi M, Matraguna N, Pirtu L. Hipertensiunea arteriala esentiala la copil. Protocol clinic national, Chisinau 2013&#13;
	Kaelber D, Pickett F. Simple Table to Identify Children and Adolescents Needing Further Evaluation of Blood Pressure, Pediatrics  2009;123(6) 6&#13;
	Tasker R, McClure R, Acerini C. Oxford Book Handbook of Pediatrics, Second Edition, Oxford Univerity Press 2008:396-403&#13;
	Banker A, Bell C, Gupta-Malhotra M,  Samuels J. Blood pressure percentile charts to identify high or low blood pressure in children, BMC Pediatr. 2016;16: 98&#13;
	Flynn JT, Kaelber DC, Baker-Smith CM, et al. AAP Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017; 140(3):e20171904&#13;
	Barnekow V, Currie C, Letsch C, de Looze M, Morgan A. A snapshot of the he alth of young people in Europe, Report prepared for the european commission conference on youth health, Brussels, Belgium, 9–10 July 2009, Publications WHO Regional Office for Europe&#13;
	Cucu A,coord. Raportul national de sanatate a copiilor si tinerilor din Romania 2016, Institutul National de Sanatate Publica din Romania, oct.2016&#13;
	Dorobantu M, Darabont RO, Badila E,  Ghiorghe S. Prevalence, Awareness, Treatment, and Control of Hypertension in Romania: Results of the SEPHAR Study, International Journal of Hypertension 2010, Article ID 970694, 6 pages http://dx.doi.org/10.4061/2010/970694&#13;
	Totaro S, Rabbia F, Rabbone I, Covella M, Berra E, Fulcheri C, Di Monaco S, Testa E, Veglio F.  Comparison among Different Screening Tests for Diagnosis of Adolescent Hypertension, ISRN Hypertension Volume 2013  Article ID 107915, 3 pages, http://dx.doi.org/10.5402/2013/107915&#13;
	Anyaegbu E, Dharnidharka V. Hypertension in the teenager, Pediatr Clin North Am. 2014; 61(1):131–151.&#13;
	Lurbe E, Torro I, Alvarez V, Nawrot T, Paya R, Redon J, Staessen J. Prevalence, Persistence, and Clinical Significance of Masked Hypertension in Youth, Hypertension 2005;45:493 – 498&#13;
	Ewald R , Haldeman L. Risk Factors in Adolescent Hypertension, Global Pediatric Health. 2016;3, Publishedonline 2016.feb.16, doi:  10.1177/2333794X15625159  &#13;
	Aglony M, Acevedo M, Ambrosio G. Hypertension in adolescents 2009;7(12):1595-603&#13;
	Rodriguez-Cruz E, Chief Editor: Syamasundar Rao Patnana.  Pediatric Hypertension&#13;
	Xi B, Zhang T, Li S, Harville E, Bazzano L, He J, Chen W. Can Pediatric Hypertension Criteria Be Simplified? A Prediction Analysis of Subclinical Cardiovascular Outcomes From the Bogalusa Heart Study, Hypertension. 2017;69(4):691-696.&#13;
	Flynn JT, Kaelber DC, Baker-Smith CM, et al. AAP Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 2017; 140(3):e20171904&#13;
	Carta European? a Sanatatii Cardiovasculare</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>